Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Corymbiferin, a chemical compound, exhibits significant anti-diabetic properties by enhancing antioxidant capacity and carbohydrate metabolism in diabetic rodents. In addition, Corymbiferin promotes the improvement of histopathology in both the liver and pancreatic β cells.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Corymbiferin, a chemical compound, exhibits significant anti-diabetic properties by enhancing antioxidant capacity and carbohydrate metabolism in diabetic rodents. In addition, Corymbiferin promotes the improvement of histopathology in both the liver and pancreatic β cells. |
In vivo | Administering Corymbiferin to male Wistar rats at a dosage of 40 mg/kg orally significantly lowers the fasting blood glucose (FBG) level, closely mirroring the beneficial impact observed with metformin in diabetic rats[1]. Furthermore, a higher dose of Corymbiferin (400 mg/kg; orally) markedly decreases the blood glucose level and demonstrates an efficacy akin to that of metformin in the oral glucose tolerance test (OGTT)[1]. |
Molecular Weight | 304.25 |
Formula | C15H12O7 |
CAS No. | 5042-09-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Corymbiferin 5042-09-1 inhibitor inhibit